• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: February 2-6, 2009

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Frank Torti, Acting Commissioner2/2/2009San Francisco, CAPam PisnerDavid Parkinson, (Nodality)Meeting with Nodality Senior staff regarding FDA Science Board Activities 
Frank Torti, Acting Commissioner2/3/2009San Francisco, CAPam PisnerArt Levinson, Sue Hellman, Mary Silwkowski, Pat Yang, Todd Rich, Hal Barron, Cathy Hollenbach (Genentech)Meeting regarding  biotech industry issues
Frank Torti, Acting Commissioner2/3/2009San Francisco, CAPam PisnerDavid Kessler (University of Southern California)FDA  management issues
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer2/2/09 through 2/6/09N/AN/AN/ANo significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs2/2/09 through 2/4/09Basel, SwitzerlandN/AN/ASession Chair and Lectured at the University of Basel's 2009 European Center of Pharmaceutical Course
Randall Lutter, Deputy Commissioner for Policy2/2/09 through 2/6/09N/AN/AN/ANo significant meetings
Janet Woodcock, Director, Center for Drug Evaluation and Research2/4/2009Silver Spring, MarylandRachel Behrman, Melissa RobbRay Woosley,MD, Mark McClellan, MDCoalition Against Major Diseases Meeting
Janet Woodcock, Director, Center for Drug Evaluation and Research2/4/2009Washington, DCRachel Behrman, MD, Thomas Scarnecchia, FNIHObservational Medical Outcomes Partnership, Executive Board Meeting
Janet Woodcock, Director, Center for Drug Evaluation and Research2/5/2009Bethesda, MDN/AN/APrinciples of Clinical Pharmacology Lecture
Michael Chappell, Acting Associate Commissioner, Office of Regulatory Affairs2/2/09 through 2/6/09N/AN/AN/ANo significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research02/03-04/09Washington, D.C.N/AN/AGovernment Liaison Group of the National Academies Standing Committee on Use of Emerging Science for Environmental Health Decisions
Daniel Schultz, Director, Center for Devices and Radiological Health2/6/2009Bethesda MDN/AN/AInternational Society for Computerized Electrocardiology (ISCE) conference
Stephen Sundlof, Center for Food Safety and Applied Nutrition2/2/09 through 2/6/09N/AN/AN/ANo significant meetings
Bernadette Dunham, Director, Center for Veterinary Medicine2/2/09 through 2/6/09N/AN/AN/ANo significant meetings
William Slikker, Director, National Center for Toxicological Research2/3-4/09Washington, D.C.N/AN/AGovernment Liaison Group of the National Academies Standing Committee on Use of Emerging Science for Environmental Health Decisions
Jeffrey M. Senger, Acting Chief Counsel2/2/09 through 2/6/09N/AN/AN/ANo significant meetings